Pharmaceuticals

Global Biopharmaceutical Excipients Market Report 2026–2035: Key Forecasts and Growth Areas

February 12, 2026February 12, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the biopharmaceutical excipients market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Biopharmaceutical Excipients Market between 2026 and 2030?

The biopharmaceutical excipients market has experienced robust expansion in recent years. Projections indicate it will increase from $3.27 billion in 2025 to $3.57 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. Historically, this growth can be attributed to factors such as an uptick in biologic drug approvals, the prompt adoption of protein stabilizers, an increase in injectable formulations, the broader scope of vaccine development, and advancements in formulation science.

The biopharmaceutical excipients market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $5.04 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.0%. Factors contributing to this growth during the forecast period include the increasing intricacy of biologic formulations, a surging need for products with extended shelf lives, the broadening scope of cell and gene therapies, heightened regulatory scrutiny on excipient safety, and greater investments in sophisticated drug delivery systems. Key trends anticipated during the same period involve a heightened demand for high-purity biologic excipients, the increasing adoption of multifunctional ingredients in formulations, an expansion of excipient applications for cell and gene therapies, an elevated emphasis on compounds that improve stability, and greater customization of excipient solutions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30214&type=smp

Which Drivers Are Expected To Impact The Biopharmaceutical Excipients Market During The Forecast Period?

The increasing need for creating vaccines is anticipated to drive the expansion of the biopharmaceutical excipients market in the future. Developing vaccines involves the creation and formulation of immunizations aimed at preventing infectious illnesses and enhancing public well-being, necessitating premium excipients to guarantee the robustness, effectiveness, and security of vaccine offerings. This rising demand for vaccine creation arises from a worldwide emphasis on combating infectious illnesses, boosting readiness in public health, and speeding up research to provide quicker and more potent immunization options. Biopharmaceutical excipients are crucial in vaccine formulations, as they stabilize antigens, improve solubility, and preserve structural integrity throughout their storage and distribution. For example, by 2025, data from the Centers for Disease Control and Prevention, a national public health agency based in the US, indicated that adolescent vaccination rates for essential vaccines like tetanus, diphtheria, and acellular pertussis climbed from 89.9% in 2022 to 91.3% in 2024. During the identical timeframe, coverage for the meningococcal conjugate vaccine increased from 88.6% to 90.1%, while human papillomavirus vaccine coverage (≥2 doses) saw a substantial rise from 76.0% to 92.6%. Consequently, the escalating requirement for vaccine creation is propelling the expansion of the biopharmaceutical excipients market.

Which Segments Are Driving Activity In The Biopharmaceutical Excipients Market?

The biopharmaceutical excipients market covered in this report is segmented –

1) By Product Types: Binders, Coatings, Diluents, Disintegrants, Lubricants And Glidants, Polyols, Preservatives, Solubilizers And Surfactants Or Emulsifiers, Suspending And Viscosity Agents

2) By Type Of Biologics: Antibodies, Vaccines, Cell Therapies, Other Biologics

3) By Functionality: Fillers And Diluents, Binders, Suspending And Viscosity Agents, Flavouring Agents And Sweeteners, Coating Agents, Colourants, Disintegrants, Lubricants And Glidants, Preservatives

4) By Application: Injectable Formulations, Oral Formulations, Topical Formulations, Transdermal Formulations, Cell and Gene Therapy

5) By End Users: Biopharmaceutical Companies And Pharmaceutical Companies, Contract Manufacturers, Research Institutes

Subsegments:

1) By Binders: Starch Binders, Cellulose Binders, Synthetic Binders, Natural Polymer Binders

2) By Coatings: Film Coatings, Sugar Coatings, Enteric Coatings, Polymer Coatings

3) By Diluents: Lactose, Microcrystalline Cellulose, Starch, Mannitol

4) By Disintegrants: Crosslinked Cellulose, Starch Derivatives, Crospovidone, Sodium Starch Glycolate

5) By Lubricants And Glidants: Magnesium Stearate, Stearic Acid, Talc, Silicon Dioxide

6) By Polyols: Sorbitol, Mannitol, Glycerol, Xylitol

7) By Preservatives: Parabens, Benzoates, Sorbates, Phenols

8) By Solubilizers And Surfactants Or Emulsifiers: Polysorbates, Polyethylene Glycol, Lecithin, Sodium Lauryl Sulfate

9) By Suspending And Viscosity Agents: Cellulose Derivatives, Xanthan Gum, Guar Gum, Carbomers

Which Innovation Trends Are Advancing Developments Within The Biopharmaceutical Excipients Market?

Leading companies in the biopharmaceutical excipients market are concentrating on technological advancements, such as ultra-high purity surfactants, to enhance protein stability, prevent degradation, and support regulatory adherence in injectable formulations. Ultra-high purity surfactants are specifically refined surface-active agents featuring minimal impurities and a consistent composition, engineered to ensure stability, safety, and performance within sensitive pharmaceutical and biopharmaceutical formulations. For instance, in September 2025, Evonik Industries AG, a Germany-based chemicals company, introduced MaxiPure Polysorbate 80 for injectable and biopharmaceutical applications. This excipient is formulated with an oleic acid content exceeding ninety-eight percent, remarkable clarity, and complete conformity with European Pharmacopoeia, United States Pharmacopoeia, Japanese Pharmacopoeia, and Chinese Pharmacopoeia standards. It addresses significant challenges in protein stability, prevents oxidative degradation, allows for consistent solubilization of hydrophobic active pharmaceutical ingredients, and strengthens the reliability of formulations. Through the integration of this excipient, Evonik empowers pharmaceutical and biopharmaceutical companies to efficiently develop complex biologics and injectable therapies while ensuring both safety and compliance.

Which Key Players Are Driving Competition In The Biopharmaceutical Excipients Market?

Major companies operating in the biopharmaceutical excipients market are The Archer-Daniels-Midland Company, BASF SE, The Dow Chemical Company, Mitsubishi Chemical Group Corporation, Novo Nordisk A/S, Associated British Foods plc, Merck KGaA, Asahi Kasei Corporation, Evonik Industries AG, Kerry Group plc, Wacker Chemie AG, Clariant AG, Shin-Etsu Chemical Co. Ltd., Roquette Frères, IMCD Group N.V., Croda International Plc, Ashland Global Holdings Inc., NOF Corporation, Colorcon Limited, J. Rettenmaier & Söhne GmbH + Co. KG, Spectrum Chemical Manufacturing Corporation, BioSpectra Inc., Sigachi Industries Limited, DFE Pharma, FUJIFILM Toyama Chemical Co. Ltd, Kirsch Pharma GmbH, Meggle Group GmbH, InVitria Inc., BOC Sciences Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/global-biopharmaceutical-excipients-market-report

Which Region Is Projected To Lead The Biopharmaceutical Excipients Market During The Forecast Period?

North America was the largest region in the biopharmaceutical excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Biopharmaceutical Excipients Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30214&type=smp

Browse Through More Reports Similar to the Global Biopharmaceutical Excipients Market 2026, By The Business Research Company

Pharmaceutical Excipient Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Organic Pharmaceutical Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/organic-pharmaceutical-excipients-global-market-report

Nutraceutical Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/nutraceutical-excipients-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795